Back to search

Article

Metabolomic profiling of pancreatic adenocarcinoma reveals fundamental clinical features

2021-02-02

Abstract excerpt

In this study, we perform the metabolomics profiling of 77 PDAC patient-derived tumor xenografts (PDTX) to investigate the relationship of metabolic profiles with overall survival (OS) in PDAC patients, tumor phenotypes and resistance to five anticancer drugs (gemcitabine, oxaliplatin, docetaxel, SN-38 and 5-Fluorouracil). We identified a metabolic signature that was able to predict the clinical outcome of PDAC pa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c22f1838-192e-5f0c-a2b5-7eba12a56fe9
DOI
10.1101/2021.02.01.429087
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Metabolomic profiling of pancreatic adenocarcinoma reveals fundamental clinical featuresDOI 10.1101/2021.02.01.429087
Select a neighboring publication to make it the new centre.